Manufacturing, Biologic Drugs

Lonza Opens Dedicated Cell and Gene Therapy Manufacturing Facility

April 10, 2018

The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.

FDA Issues CRLs to Celltrion for Two Biosimilars

April 09, 2018

Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

April 05, 2018

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.

AGC Biologics to Add New Facilities at Headquarters

April 05, 2018

Pharmaceutical Technology's In the Lab eNewsletter

The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.

Modernizing Pharma Manufacturing

April 02, 2018

The pharmaceutical industry is adopting Industry 4.0 and emerging technologies to improve product quality and manufacturing efficiency.

Hitachi to Manufacture Regenerative Medicines

March 26, 2018

Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.

Cesca Licenses CAR-T Cellular Processing Services to China’s Boyalife Group

March 26, 2018

The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.

Helix BioPharma Partners with ProMab on CAR-T Therapies

March 23, 2018

The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.

Wuxi Biologics to Install Large-Scale Single-Use Bioreactor

March 22, 2018

The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.

Ambr 250 High Throughput Bioreactor System Speeds Up Intensified Cell Culture Process Development

March 19, 2018

Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.